Org chart
Roger D. Tung
Co-Founder, President & CEO
Roger D. Tung
Collapse
Nancy Stuart
Chief Operating Officer
James V. Cassella
Chief Development Officer
Jeffrey A. Munsie
Chief Legal Officer
Justine E. Koenigsberg
SVP, Corporate Communications & Investor Relations
Christine Boisclair
VP, Regulatory Affairs & Quality Assurance
Cameron J. Cowden
VP, Pharmaceutical Development
Christopher L. Brummel
VP, Drug Metabolism, Pharmacokinetics & Bioanalysis
K. Mitch Goldenberg
VP, IT & Infrastructure
Nabil Uddin
VP, Corporate Development
Ken Goldenberg (Mitch)
Vice President, IT And Infrastructure
Bob Zelle
VP Drug Development
Kristine Hogan
Senior Principal Investigator
Karen Merrill
Accountant II
